N/A
N=107
Investigating How Incentives Impact Engagement With an Online Mental Health Application (Neuroflow)
Behavioral Economics · Gifts, Financial · Point
Bottom Line
View on ClinicalTrials.gov: NCT05121675 ↗Enrolled (actual)
107
Serious AEs
0.0%
Results posted
Aug 2024
Primary outcome: Primary: Engagement (Percentage of Daily check-in Activities) — 32.8176; 30.242 percentage of completion
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Neuroflow app: Mental health and wellbeing resources for adults (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Pennsylvania
- Primary completion
- Apr 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Engagement (Percentage of Daily check-in Activities) |
32.8176; 30.242 | — |
| SECONDARY Generalized Anxiety Disorder (GAD-7) |
6.58; 6.71; 4.45; 5.19 | — |
| SECONDARY Patient Health Questionnaire (PHQ-8) |
5.45; 6.08; 4.62; 5.3 | — |
| SECONDARY World Health Organization (WHO-5) |
57.95; 55.9; 58.89; 61.45 | — |
| SECONDARY Difficulties Emotion Regulation Scale (DERS) |
83.29; 83.22; 76.36; 74.32 | — |
Summary
The purpose of the study is to understand how incentives (either points alone or points that can be exchanged for gift certificates) encourage engagement with an online mental health app (Neuroflow) for University students. Overall, the hope of this study is to help the investigators understand how best to support mental health and wellness in university students.
Eligibility Criteria
Inclusion Criteria
- The target population for this study are college students either at the University of Pennsylvania or other US universities. Participants will be included if they have a smartphone and are willing to download and use the Neuroflow app throughout the duration of the study
Exclusion Criteria
- Does not own a smartphone capable of downloading the NeuroFlow application or is unwilling to download and use the Neuroflow app throughout the duration of the study.
Data sourced from ClinicalTrials.gov (NCT05121675). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.